Department of Medicine, Pennsylvania Hospital, University of Pennsylvania Health System, Philadelphia, USA.
Department of Medicine, Pennsylvania Hospital, University of Pennsylvania Health System, Philadelphia, USA.
Respir Med. 2020 Jan;161:105825. doi: 10.1016/j.rmed.2019.105825. Epub 2019 Nov 19.
Interstitial lung disease represents a group of diffuse parenchymal lung diseases with overwhelming morbidity and mortality when complicated by acute respiratory failure. Recently, trials investigating outcomes and their determinants have provided insight into these high mortality rates. Pulmonary hypertension is a known complication of interstitial lung disease and there is high prevalence in idiopathic pulmonary fibrosis, connective tissue disease, and sarcoidosis subtypes. Interstitial lung disease associated pulmonary hypertension has further increased mortality with acute respiratory failure, and there is limited evidence to guide management. This review describes investigations and management of interstitial lung disease associated acute respiratory failure complicated by pulmonary hypertension. Despite the emerging attention on interstitial lung disease associated acute respiratory failure and the influence of pulmonary hypertension, critical care management remains a clinical and ethical challenge.
间质性肺疾病是一组弥漫性肺实质疾病,当合并急性呼吸衰竭时,其发病率和死亡率极高。最近,对预后及其决定因素进行的研究为这些高死亡率提供了深入了解。肺动脉高压是间质性肺疾病的已知并发症,在特发性肺纤维化、结缔组织疾病和结节病亚型中发病率很高。间质性肺疾病相关肺动脉高压合并急性呼吸衰竭时死亡率进一步增加,而管理方面的证据有限。本文综述了间质性肺疾病相关急性呼吸衰竭合并肺动脉高压的检查和治疗。尽管间质性肺疾病相关急性呼吸衰竭及其肺动脉高压的影响引起了人们的关注,但重症监护管理仍然是一个临床和伦理挑战。